HOME >> BIOLOGY >> NEWS
UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research

Dallas -- July 25, 2006 -- Dr. Russell DeBose-Boyd, assistant professor of molecular genetics at UT Southwestern Medical Center, has been named a Distinguished Young Scholar in Medical Research by the Los Angeles-based W.M. Keck Foundation.

The award of up to $1 million over five years will support the researcher's work on the enzymes that regulate and control cholesterol production, studies that may shed light on the prevention and treatment of heart disease.

"I'm honored to be included among such a distinguished group of young investigators," said Dr. DeBose-Boyd, one of five Keck Young Scholar winners nationwide this year. "This generous award will allow my lab to continue our efforts to understand the enzyme HMG CoA reductase, a key player in cholesterol synthesis and the target of cholesterol-lowering statin drugs.

"I'm grateful to the W.M. Keck Foundation for this support that allows young researchers to explore novel projects and take on new challenges in high-risk areas that could lead to important medical breakthroughs," he said.

A native of Boswell, Okla., Dr. DeBose-Boyd received his bachelor's degree in chemistry from Southeastern Oklahoma State University and his doctorate in biochemistry and molecular biology from the University of Oklahoma Health Sciences Center. Before joining the faculty of UT Southwestern as an instructor in 2001, he was a postdoctoral fellow in the molecular genetics laboratory of two of UT Southwestern's four Nobel laureates, Dr. Michael Brown and Dr. Joseph Goldstein. As a young faculty member at UT Southwestern Dr. DeBose-Boyd's early research was supported by the Perot Foundation.

Dr. DeBose-Boyd said being named a Keck Young Scholar is a reflection of the scientific environment in the Department of Molecular Genetics at UT Southwestern in general.

"This institution encourages young scientists, and provides tremendously talented mentors. I wouldn't be here if it w
'"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
25-Jul-2006


Page: 1 2 3

Related biology news :

1. UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
2. UT Southwestern leaders to receive national award for medical research accomplishments
3. UT Southwestern scientist receives NIH Directors Pioneer Award
4. UT Southwestern researchers find gene mutation that leads to broken hearts
5. Plague agent helps UT Southwestern researchers find novel signaling system in cells
6. One of the nations first 7-Tesla magnetic resonance imaging devices for human studies planned at UT Southwestern Medical Center
7. DNA end caps may lead to cancer treatments, UT Southwestern researchers report
8. UT Southwestern scientist honored among best in Texas research
9. UT Southwestern scientist receives international award for pediatric research
10. UT Southwestern physician-researcher wins international award for lipid research
11. UT Southwestern scientist elected to National Academy of Sciences Institute of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
Cached News: